Key facts
- It has raised $1.0M; the latest was Later Stage VC in Dec 2024.
- Notable investors include Tech Incubator Program for Startup, Murex Partners, BSK Investment, Clairvoyant Ventures, Sneak Peek Investments — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Dotter
- ·The full record, as it builds
Funding rounds
No funding rounds for Dotter are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dotter
Developer of medical diagnostic devices designed for detecting and intervening in cardiovascular diseases. The company develops an optical coherence tomography imaging device that assists in accurately observing lesions during PCI procedures and provides information for stent selection by using its double-lumen percutaneous coronary angioplasty (PTCA) catheter that has a balloon positioned at the distal end, enabling healthcare professionals and surgeons with accurate diagnostic images and surgical equipment.
- Sector
- Healthcare
- HQ
- Incheon, South Korea
- Founded
- 2016
- Employees
- 13
- Website
- dotter.com/
- Ownership
- Privately Held (backing)
Dotter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dotter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dotter in its N-PORT filings yet. We sweep new filings monthly.